糖尿病患者的支架選擇-免費閱讀
【正文】 mol/L), total lesion length per vessel 27 mm, ≥2 lesions per vessel, lesion with thrombus, or lesion with total occlusion. 所有糖尿病患者 N = 1535 標(biāo)準(zhǔn)風(fēng)險患者 FDA 適應(yīng)證 Yeung A. ACC 2020 RESOLUTE糖尿病薈萃 研究 Resolute獲得 FDA糖尿病適應(yīng)證的臨床證據(jù) * Performance goal based on DES trials metaanalysis: DIABETES, RAVEL DM, SIRIUS DM, TAXUS IV, SCORPIUS, ENDEAVOR Pooled DM. ? RESOLUTE matched cohort diabetes pooled analysis (n = 878). Windecker S. Presented at EuroPCR. 2020. Resolute 應(yīng)用于糖尿病患者，顯著降低靶血管失敗率（ TVF） TLR is ischemia driven. 所有糖尿病 患者 – 24個月臨床結(jié)果 1 3 . 41 1 . 15 . 83 . 43 . 81 . 2TLR Cardiac Death TVMI ST (ARC Def/Prob) TLF Events (%) RESOLUTE Pooled analysis, All diabetics (n=1510/1535) TVF The RESOLUTE Pooled analysis was not specifically designed or powered for the analysis shown above. 所有糖尿病患者 – 2年 TLF % % 0 Time After Initial Procedure (months) Diabetics (N = 1535) Cumulative Incidence of TLF 6 12 18 24 % % No. at risk NonDiabetics 3595 3540 3399 3301 3198 Diabetics 1535 1518 1447 1386
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號-1